(Q54601832)

1 June 2018

title

The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancer. (English)

1 reference

1 June 2018

6

Wilma L Lingle

1 reference

1 June 2018

author name string

Monica Brown Jones

1

1 reference

1 June 2018

Aletta P Houwink

2

1 reference

1 June 2018

Brandi K Freeman

3

1 reference

1 June 2018

Tammy M Greenwood

4

1 reference

1 June 2018

Jacqueline M Lafky

5

1 reference

1 June 2018

Andrew Berchuck

7

1 reference

1 June 2018

G Lawrence Maxwell

8

1 reference

1 June 2018

Karl C Podratz

9

1 reference

1 June 2018

Nita J Maihle

10

1 reference

1 June 2018

publication date

1 May 2006

1 reference

1 June 2018

Journal of the Society for Gynecologic Investigation

published in

1 reference

1 June 2018

volume

13

1 reference

1 June 2018

issue

4

1 reference

1 June 2018

page(s)

304-311

1 reference

1 June 2018

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Two pathogenetic types of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Induction of granulin precursor gene expression by estrogen treatment in neonatal rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Granulin precursor gene: a sex steroid-inducible gene involved in sexual differentiation of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Progranulin (acrogranin/PC cell-derived growth factor/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Inhibition of tumorigenicity of the teratoma PC cell line by transfection with antisense cDNA for PC cell-derived growth factor (PCDGF, epithelin/granulin precursor)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

The granulin/epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Identification of a sex steroid-inducible gene in the neonatal rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Stimulation of PC cell-derived growth factor (epithelin/granulin precursor) expression by estradiol in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Differential regulation of TCR-mediated gene transcription by Vav family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Molecular determinants for the tissue specificity of SERMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Overview of the main outcomes in breast-cancer prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

KLE: a cell line with defective estrogen receptor derived from undifferentiated endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.03.003

10.1016/J.JSGI.2006.03.003

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

16697948

1 reference

1 June 2018